Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A2.Business profile
Premedium Clinical Trial Consulting Oy
Premedium Clinical Trial Consulting Oy's registered office is Paimio. It is a limited company. The company was established on 2025-02-17. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2026-06-30, revenue was €71,741 and operating profit was €17,225.
Business ID 3510393-1ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 3510393-1
- Sector
- Other human health activities n.e.c.
- Municipality
- Paimio
- Company form
- Limited company
- Registration date
- 2025-02-17
- Business ID registration date
- 2025-02-12
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: MEIJERITIE 3 C 19, 21530, Paimio
About Premedium Clinical Trial Consulting Oy
Financial position and key figures for the company.
Premedium Clinical Trial Consulting Oy's location municipality is Paimio. It is a limited company. The company was established on 2025-02-17. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2026-06-30, revenue was €71,741 and operating profit was €17,225. The latest retained financial statement for 2026-06-30 shows revenue of €71,741 and profit for the financial year of €13,650. Based on the latest retained statement, revenue growth was not currently available, operating margin was +24.0%, and equity ratio was +70.8%.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2026-06-30
1
1
PRH/XBRL financial statement
Derived indicators
Operating margin24.0%
Equity ratio70.8%
Balance-sheet contextLatest financial period
Cash and bank€16,450Previous: No comparison value
Equity€13,650Previous: No comparison value
Liabilities€5,635Previous: No comparison value
Current assets€19,285Previous: No comparison value
Current liabilities€5,635Previous: No comparison value
Financial ratios
Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.
Equity ratioGood
88/100 · Trend unavailable
Current ratioGood
97/100 · Trend unavailable
Operating profit marginGood
100/100 · Trend unavailable
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID3510393-1
VAT IDFI35103931
EU IDFIFPRO.3510393-1
MunicipalityPaimio
Current registered entries
2025-02-12Registered in Tax Administration (Prepayment Register)
2025-02-17Registered in Tax Administration (Tax Administration)
2025-02-17Registered in Patent and Registration Office (Trade Register)
2025-05-01VAT-liable for business activity in Tax Administration (VAT Register)
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
A2
Very goodPremedium Clinical Trial Consulting Oy
Grade unchangedA2 · new analysis 2026-10-17
80/100
Medium
Usable financial evidenceFinancial data included
Same industry and sizeDescriptive comparison – does not change the model score.
83 peersSolvency43%
Below 57% of peers
Profitability69%
Better than 69% of peers
Liquidity66%
Better than 66% of peers
Limited evidenceBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
1 observed filings56 days after period end
56 days after period end
1 consecutive periods
Supporting factors
- Strong equity ratio
- Strong operating profitability
- Healthy short-term liquidity
Risk factors to note
No material separate warning signals.
Automatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessmentsA2
2026-10-1780/100 · v0.15
A2 → A2A2
2026-09-18 01:0880/100 · v0.14
B2 → A2 · +26 points- Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2026-06-30).
- Evidence quality: Registry and statistical evidence → Usable financial evidence.
B2
2026-09-1454/100 · v0.14
B2 → B2B2
2026-09-1454/100 · v0.13
Oldest retained automatic assessment in this comparisonA2
2026-10-17
open-risk-grade-v0.15
The grade can use open digital financial statement data together with registry signals.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry riskvery low
92/100
Industry context is very low based on normalized open statistical inputs.
Age and continuityNuori
10/100
The company has about 1 years of registry continuity.
Registry and status signalsRajallinen
32/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Risk grade updatedRisk gradeEvidence verified
18 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2 → A2.Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.Financial statement availableFinancialEvidence verified
25 Aug 2026 · PRH / XBRLFinancial period ends 2026-06-30.Registry timeline
Trade register notifications shown on a timeline.
4 register eventsLatest event: 2025-04-02
Financial statements availability
Available financial statement periods and PRH source filings.
1 financial statement periodsLatest financial period: 2026-06-30
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
Premedium Clinical Trial Consulting Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.